| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |